Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ArcherDX, LLC et al v. QIAGEN Sciences, LLC et al
Case Number:
1:18-cv-01019
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
October 03, 2022
Judge Won't Hold New Trial In Genetic Testing Patent Feud
A Delaware federal judge has rebuffed a biotechnology company's bid for a new trial after a jury determined it owed a rival and Massachusetts General Hospital $4.7 million for infringing their genetic testing patents, while agreeing with some of the plaintiffs' requests to boost their award.
-
August 27, 2021
Jury Awards $4.7M In Mass. General Genetic Test Patent Trial
A Delaware federal jury on Friday found that European genetic testing company Qiagen willfully infringed a pair of patents owned by Massachusetts General Hospital and biotech company ArcherDX, awarding royalties and lost profits totaling about $4.7 million.
-
August 19, 2021
IP Forecast: Ferring Seeks Sanctions Against Jones Day
Ferring Pharmaceuticals will argue next week that Jones Day should be sanctioned for sparking a patent trial that never should have happened. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.